Education
About Us
Working with TipRanks
Follow Us
Firebrick Pharma Limited (AU:FRE)
ASX:FRE
Total Valuation
Firebrick Pharma Limited has a market cap or net worth of AU$13.58M. The enterprise value is AU$12.77M.
Market CapAU$13.58M
Enterprise ValueAU$12.77M
Share Statistics
Firebrick Pharma Limited has 251,571,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding251,571,370
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Firebrick Pharma Limited’s return on equity (ROE) is -1.69 and return on invested capital (ROIC) is -168.60%.
Return on Equity (ROE)-1.69
Return on Assets (ROA)-1.44
Return on Invested Capital (ROIC)-168.60%
Return on Capital Employed (ROCE)-1.84
Revenue Per Employee10.00T>
Profits Per Employee―
Employee Count―
Asset Turnover0.16
Inventory Turnover0.97
Valuation Ratios
The current PE Ratio of Firebrick Pharma Limited is ―. Firebrick Pharma Limited’s PEG ratio is -0.06.
PE Ratio―
PS Ratio44.43
PB Ratio8.38
Price to Fair Value8.38
Price to FCF-7.00
Price to Operating Cash Flow-7.75
PEG Ratio-0.06
Income Statement
In the last 12 months, Firebrick Pharma Limited had revenue of 293.42K and earned -2.63M in profits. Earnings per share was -0.01.
Revenue293.42K
Gross Profit104.82K
Operating Income-2.87M
Pretax Income-2.63M
Net Income-2.63M
EBITDA-2.86M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.78M and capital expenditures -82.98K, giving a free cash flow of -1.86M billion.
Operating Cash Flow-1.78M
Free Cash Flow-1.86M
Free Cash Flow per Share>-0.01
Dividends & Yields
Firebrick Pharma Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.71
52-Week Price Change0.00%
50-Day Moving Average0.06
200-Day Moving Average0.07
Relative Strength Index (RSI)17.24
Average Volume (3m)91.61K
Important Dates
Firebrick Pharma Limited upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
Firebrick Pharma Limited as a current ratio of 5.47, with Debt / Equity ratio of 0.00%
Current Ratio5.47
Quick Ratio4.75
Debt to Market Cap0.00
Net Debt to EBITDA0.34
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Firebrick Pharma Limited has paid -222.09K in taxes.
Income Tax-222.09K
Effective Tax Rate0.08
Enterprise Valuation
Firebrick Pharma Limited EV to EBITDA ratio is -4.22, with an EV/FCF ratio of -6.47.
EV to Sales41.08
EV to EBITDA-4.22
EV to Free Cash Flow-6.47
EV to Operating Cash Flow-6.78
Balance Sheet
Firebrick Pharma Limited has AU$983.35K in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$983.35K billion.
Cash & Marketable SecuritiesAU$983.35K
Total DebtAU$0.00
Net CashAU$983.35K
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 63.41%, with operating margin of -976.65%, and net profit margin of -897.83%.
Gross Margin63.41%
Operating Margin-976.65%
Pretax Margin-897.83%
Net Profit Margin-897.83%
EBITDA Margin-973.71%
EBIT Margin-976.65%
Analyst Forecast
The average price target for Firebrick Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast1920.53%
EPS Growth Forecast-89.39%